
TARS
Healthcare · Biotechnology · $3.96B market cap
$80.28+3.39 (+4.4%)Nov 13, 4:20 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -525.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2026 | After the close | -1.43 | -0.78 | +45.5% |
| Aug 6, 2026 | Before the open | -0.21 | -0.43 | -104.8% |
| May 6, 2026 | After the close | -0.42 | -0.16 | +61.9% |
| Mar 16, 2026 | Time not confirmed | -0.08 | -0.20 | -139.2% |
| Nov 4, 2025 | After the close | -0.33 | -0.30 | +9.1% |
| Aug 6, 2025 | After the close | -0.36 | -0.48 | -33.3% |
| May 1, 2025 | After the close | -0.63 | -0.64 | -1.6% |
| Feb 25, 2025 | Before the open | -0.82 | -0.60 | +26.4% |
| Nov 13, 2024 | After the close | -1.00 | -0.61 | +39.0% |
| Aug 8, 2024 | After the close | -0.80 | -0.83 | -3.8% |
| May 8, 2024 | After the close | -1.25 | -0.99 | +20.8% |
| Feb 27, 2024 | Before the open | -1.36 | -1.31 | +3.7% |
| Nov 9, 2023 | After the close | -1.27 |
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics,…
| -1.27 |
| 0.0% |
| Aug 10, 2023 | After the close | -1.02 | -1.17 | -14.7% |
| May 9, 2023 | After the close | -0.91 | -0.87 | +4.4% |
| Mar 13, 2023 | After the close | -0.69 | -0.49 | +29.0% |
| Nov 9, 2022 | Before the open | -1.07 | -0.84 | +21.5% |
| Aug 11, 2022 | After the close | -0.50 | -0.22 | +56.0% |
| May 10, 2022 | After the close | -1.06 | -0.96 | +9.4% |
| Mar 14, 2022 | After the close | -0.73 | -0.72 | +1.4% |
| Nov 9, 2021 | After the close | -0.47 | -0.76 | -61.7% |
| Aug 4, 2021 | After the close | -0.33 | 0.33 | +200.0% |
| May 11, 2021 | After the close | -0.13 | 0.47 | +461.5% |
| Mar 31, 2021 | After the close | -0.66 | -0.68 | -3.0% |
| Nov 25, 2020 | Before the open | -0.54 | -0.50 | +7.4% |
| Sep 2, 2020 | Time not confirmed | -0.46 | -0.19 | +57.6% |